Skip to main content

and
  1. Article

    Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation

    To determine the efficacy and toxicities of sorafenib in the treatment of patients with multiple recurrences of hepatocellular carcinoma (HCC) after liver transplantation in a Chinese population.

    Wei-feng Tan, Zhi-quan Qiu, Yong Yu, Rong-zheng Ran, Bing Yi in Acta Pharmacologica Sinica (2010)